In The News
BHP class action gets 3 extra weeks for high-stakes trial
NACC to reconsider investigating 6 people over Robodebt scheme
Ninth junior doctors class action launched after courtroom victories
Xero paid engineer less than male colleagues for taking parental leave: suit
Cipla attacks patent extension for Novo Nordisk weight loss drug
ASIC sues Oak Capital for alleged Credit Code dodge on $37M in loans
Queensland police officers file class action over COVID-19 vaccine direction
Government wants to stay 12-year-old dispute over Abilify generic
Metcash loses appeal over worker rest breaks
Medibank says Deloitte data breach report not relevant in shareholder class action
Please login to bookmarkClose

Cipla is opposing the extension of Novo Nordisk’s patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au